greatly increases cross reactivity with type XIV antipneumococcal horse serum (5, 6) .
Hog intrinsic factor concentrate (HIFC), WES 727,3 was potent in a daily oral dose of 5 mg as measured by Schilling-type testing (7) . It contained 15 to 20 per cent of blood group A activity as determined by the isohemagglutination technique (5) . Twenty-five jug of this preparation was almost sufficient to saturate the receptors in a 10 ml aliquot of 10 g of rat liver homogenate suspended in 100 ml of Krebs-Ringer-Tris (KRT) medium (2) . Other agents tested were: chondroitin sulfate (General Biochemicals, lot 26752); human chorionic gonadotropin ("Follutein," Squibb); heparin ("Liquaemin sodium," Organon); pneumococcus polysaccharides types tetraacetate (EDTA) or 0.9 per cent NaCl at 370 (Table IV) . When A and B bgp were incubated with liver homogenate without Ca++ in the medium (KRT, where Ca++ was replaced by an equivalent millimolar concentration of Na+) and HIFC was added to a subsequent incubation, the HIFC effect was minimally depressed (Table V) . Conversely, with Ca++ present in the medium during the pre-incubation with logp, the effect of subsequently added HIFC was markedly diminished (Table V) .
When the homogenate was incubated in either EDTA or 0.9 per cent NaCl after incubation with A or B-bgp or pneumococcus polysaccharide type XIV, there was no inhibition of the effect of subsequently added HIFC (Table VI) . The effect of HIFC itself, however, was still marked after incubation in 0.9 per cent NaCl but not after incubation in EDTA (Table VI) .
Some dialyzable sugars (fucose, certain oligosaccharide side chains) are released from blood group polysaccharides by mild acid hydrolysis. The nondialyzable residue (P-1 fraction) (5, 6) was resuspended in 0.9 per cent NaCl and tested (as "degraded bgp"). Less degraded bgp was needed to obtain the same "per cent inhibition" of HIFC than was obtained with intact bgp (Table  VII) . The decrease in Co60-B12 uptake was proportional-to the increased amount of the "inhibitor." The blocking of the intrinsic factor receptors by the various agents studied appears to be calcium-dependent, and reversible by removing Ca-+ from the system. The various "inhibitors" did not damage the integrity of the liver "receptors" In accor(lance with the concept of molecular conmplementarity as the basis of specificity (9), the minimal blocking effect of certain polysaccharides and the strong l)locking effect of others suggest that there is a specific moiety of polysaccharide nature involved ini the bin(ling of intrinsic factor to liver receptors.
It is l)ossilble that this moiety of intrinsic factor consists mainly of terminal f3-galactosvl groups. This is suggested by the findings that the most active "blockers" are P-1 fractions prepared from blood group substances and type XIV pneumococ- Degraded A-bgp ("P-I fractioni") 25 90
Degraded A-bgp ("P-I fraction") 10 75 Degraded A-bgp ("P-I fraction") 5 56 Degraded B-bgp ("P-I fraction") 25 85
Degraded B-bgp ("P-I fraction") 10 65 Degraded B-bgp ("P-I fraction") 5 54
* Amounts of degraded bgp are stated as the weight of instact bgp from which they were derived.
Cus pol)'saccharide, all of which react strongly wvith type XIV antipneutmococcal horse serum (5, 6) , the reaction appearing related to the presence of terminal fl-galactosyl groups (10) . The blood group sul)stances themselves are somewhat less effective as l)lockers than their P-1 fractions, and other pneumnococcus polysaccharides stud-ied are less effective than type XIV. The postulated /3-galactosyl end-group configuration may not be identical for intrinsic factor derived from different species.
These studies leave intact the concept (11) that the ability to bind to both receptor and B12 (6) .
However, refractoriness to HIFC may not be due to antigenicity of hog intrinsic factor since it has been demonstrated that sera of some patients with pernicious anemia, who have never received HIFC, inhibit the activity of HIFC (16) . Another factor to consider in the "refractory" case is that the oral administration of a poor B12-intrinsic factor product may produce only a minimal hemopoietic response (17) .
The question legitimately arises as to the general applicability of data obtained-in a heterologous system, such as the present one (HIFC with rat liver homogenate). In this connection the following points should be made. 1) rat intrinsic factor has been successfully used in place of HIFC in our experimental protocol (2). 2) Species specificity does not appear to play a role in the phase of intrinsic factor action under discussion here. Recent evidence suggests that species specificity is not involved in the attachment of intrinsic factor to receptors, but rather in the subsequent release of vitamin B1.2 from intrinsic factor by a presumed enzyme (12, 18) .
These studies may have some relation to the statistical association of pernicious anemia and blood group A, although such relationship is highly speculative (19, 20 
